Imaging Technology for Screening Skin and Other Conditions Early
Tests whole-body imaging for early detection of skin conditions in adults.
Plain-language title generated from the registry record
Registry title: Multi-modal Quantitative Imaging of the Skin
Key facts
- Where
- Stockholm, SwedenSee the 3 sites
Where in Sweden
- Atrium Health Care CentreStockholm, SwedenTaking people
- Neko Health Centre, RegeringsgatanStockholm, SwedenTaking people
- Neko Health Centre, SibyllegatanStockholm, SwedenTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- HJN Sverige AB/Neko Health
- Trial code
- NCT06989216
- Record updated
- 25 May 2025
- Original description
This clinical trial is about evaluating the suitability of multi-modal imaging technology, which covers virtually the entire body, to evaluate the possibility of screening and early detection of disease.Read full original descriptionShow less
DermaFlow Alpha - Multi-modal Quantitative Imaging of the Skin
This clinical trial is about evaluating the suitability of multi-modal imaging technology, which covers virtually the entire body, to evaluate the possibility of screening and early detection of disease.
Inclusion: Adult patients that are part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation; Patients with signed informed consent.
Exclusion: Cognitive impairment; Other severe disorder or terminal disease; Patients unable to understand the oral and written study information in Swedish or English; Patients unable to provide an informed consent; Patients not able to keep balance, while standing up with closed eyes, without any aid; Claustrophobic patients.